We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
United Health Products Inc (PK) | USOTC:UEEC | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.002 | -1.10% | 0.18 | 0.0001 | 0.4326 | 0.1999 | 0.18 | 0.1999 | 801,328 | 21:30:15 |
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2019
¨ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ____________ to ____________
Commission file number: 000-27781
UNITED HEALTH PRODUCTS, INC. |
(Exact name of Company as specified in its charter) |
Nevada |
|
84-1517723 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
10624 S. Eastern Ave., Suite A209 Henderson, NV |
|
89052 |
(Address of Company's principal executive offices) |
|
(Zip Code) |
(877) 358-3444
(Company's telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 the Securities Act. Yes ¨ No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
¨ |
Accelerated filer |
¨ |
Non-accelerated filer |
¨ |
Smaller reporting company |
x |
|
Emerging growth company |
¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
The number of shares issued of the Registrant's Common Stock, as of May 15, 2019 was 176,217,368 issued and outstanding.
|
|
EXPLANATORY NOTE
The sole purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 of United Health Products, Inc. (the “Company”) filed with the Securities and Exchange Commission on May 15, 2019 (the “Form 10-Q”) is to furnish updated Exhibits 101 to the Form 10-Q to correct typographical errors in the original filing. The cover page of the Form 10-Q has also been updated to correct typographical errors.
2 |
|
PART II
ITEM 6. EXHIBITS
Exhibit |
Incorporated by Reference |
Filed or Furnished Herewith |
||||||||
Number |
Exhibit Description |
Form |
Exhibit |
Filing Date |
||||||
101.INS |
XBRL Instance Document |
x |
||||||||
101.SCH |
XBRL Taxonomy Extension Schema Document |
x |
||||||||
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document |
x |
||||||||
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document |
x |
||||||||
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document |
x |
||||||||
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document |
x |
3 |
|
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized on May 22, 2019.
|
United Health Products, Inc. |
||
|
By: |
/s/ Douglas Beplate |
|
|
Douglas Beplate Principal Executive Officer |
|
By: |
/s/ Nate Knight |
|
|
Nate Knight |
||
|
Principal Financial Officer |
4 |
1 Year United Health Products (PK) Chart |
1 Month United Health Products (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions